Eupraxia Pharmaceuticals (EPRX) Depreciation & Amortization (CF) (2023 - 2025)
Eupraxia Pharmaceuticals' Depreciation & Amortization (CF) was $72,806 in the quarter ended Dec 31, 2025, up 33.6% from $54,512 a year earlier and up 15.6% from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Depreciation & Amortization (CF) (2023 - 2025) Analysis & Trends
For the year ended Dec 31, 2025, Depreciation & Amortization (CF) at Eupraxia Pharmaceuticals came in at $237,717, up 38.4% from the prior year.
- Depreciation & Amortization (CF) has now increased for three consecutive years, with a three-year compound annual growth rate of 17.1% (years ended Dec 2022 to Dec 2025).
- In earlier years, Depreciation & Amortization (CF) was $171,719 in the year ended Dec 31, 2024 (+10.4%), $155,527 in the year ended Dec 31, 2023 (+5.2%) and $147,894 in the year ended Dec 31, 2022.
- The figure for the quarter ended Dec 31, 2025 marks the highest quarterly Depreciation & Amortization (CF) in data going back to the quarter ended Mar 31, 2023.
- Compared with a year earlier, Depreciation & Amortization (CF) has increased for five straight quarters, with growth averaging 24.5% over the last eight quarters.
- The best year-over-year quarter for Depreciation & Amortization (CF) over five years was the quarter ended Sep 30, 2025 (growth of 66.8%); the worst was the quarter ended Sep 30, 2024 (a decline of 2.5%).
- Per Business Quant data, EPRX's Depreciation & Amortization (CF) in the three quarters before the quarter ended Dec 31, 2025 was $62,993 (quarter ended Sep 30, 2025), $55,431 (quarter ended Jun 30, 2025) and $46,487 (quarter ended Mar 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.96 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 194.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 599.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.93 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 98.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.62 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 56.50 Mn |
| 10 | Eupraxia Pharmaceuticals | 363.60 Mn | 362.00 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 72,806.00 |
| Sep 30, 2025 | 62,993.00 |
| Jun 30, 2025 | 55,431.00 |
| Mar 31, 2025 | 46,487.00 |
| Dec 31, 2024 | 54,512.00 |
| Sep 30, 2024 | 37,759.00 |
| Jun 30, 2024 | 42,030.00 |
| Mar 31, 2024 | 37,418.00 |
| Dec 31, 2023 | 41,233.00 |
| Sep 30, 2023 | 38,716.00 |
| Jun 30, 2023 | 38,122.00 |
| Mar 31, 2023 | 37,456.00 |
API Access
Eupraxia Pharmaceuticals Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();